[ Price : $8.95]
FDA approves an AstraZeneca BLA for Beyfortus (nirsevimab-alip) for preventing Respiratory Syncytial Virus lower respiratory tract...[ Price : $8.95]
Federal Register notice: FDA announces the issuance of a priority review voucher to Sarepta Therapeutics for its recently approved...[ Price : $8.95]
FDA issues a warning against using ultrasound medical devices manufactured and distributed by RoyalVibe Health, and related compan...[ Price : $8.95]
Eli Lilly reports study results showing that donanemab significantly slowed cognitive and functional decline in people with early ...[ Price : $8.95]
BridgeBio Pharma plans to file an NDA after reporting positive results from ATTRibute-CM, a Phase 3 study of acoramidis in transth...[ Price : $8.95]
Federal Register notice: FDA seeks industry organizations interested in participating in the selection of nonvoting industry repre...[ Price : $8.95]
Federal Register notice: FDA and the Clinical Trials Transformation Initiative seek patient advocates interested in participating ...[ Price : $8.95]
FDA issues Fresenius Kabis Canton, MA outsourcing facility a Form FDA-483 over GMP deviations observed during a March inspection.